I have been here for 2+ years - I was very positive then - as time passed I realized that this is another OTC co that does not have right resources, has very enthu CEO who over promises and misses the deadlines.
Also the co is not able to enroll patients and other big companies are able to finish their large enrollments much easily - so co does not have much influence to finish the trials.
All this means - more delays - more dilution without quick results
So No I do not have much positive things to say as of now. I am waiting to sell by year end and book tax losses